Accessibility Menu
 
CellaVision Ab (publ) logo

CellaVision Ab (publ)

(OTC) CLVSF

Current Price$16.14
Market Cap$384.84M
Since IPO (2010)+787%
5 Year-51%
1 Year-15%
1 Month+2%

CellaVision Ab (publ) Financials at a Glance

Market Cap

$384.84M

Revenue (TTM)

$758.97M

Net Income (TTM)

$153.08M

EPS (TTM)

$0.65

P/E Ratio

24.66

Dividend

$0.26

Beta (Volatility)

0.00 (Low)

Price

$16.14

Volume

2,000

Open

$16.14

Previous Close

$16.14

Daily Range

$16.14 - $16.14

52-Week Range

$15.45 - $19.28

CLVSF News

No articles available.

CLVSF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CellaVision Ab (publ)

Industry

Healthcare Equipment and Supplies

Employees

236

CEO

Simon Ostergaard, PhD, MBA

Headquarters

Lund, 223 62, SE

CLVSF Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

27%

Net Income Margin

20%

Return on Equity

18%

Return on Capital

21%

Return on Assets

14%

Earnings Yield

4.06%

Dividend Yield

0.02%

Payout Ratio

38.95%

Stock Overview

Market Cap

$384.84M

Shares Outstanding

23.85M

Volume

2.00K

Short Interest

0.00%

Avg. Volume

58.361

Financials (TTM)

Gross Profit

$519.88M

Operating Income

$202.07M

EBITDA

$236.69M

Operating Cash Flow

$200.53M

Capital Expenditure

$86.27M

Free Cash Flow

$114.26M

Cash & ST Invst.

$188.22M

Total Debt

$25.65M

CellaVision Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$197.21M

+5.6%

Gross Profit

$131.79M

+2.0%

Gross Margin

66.83%

N/A

Market Cap

$384.84M

N/A

Market Cap/Employee

$1.69M

N/A

Employees

228

N/A

Net Income

$42.61M

+4.1%

EBITDA

$55.49M

-13.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$162.56M

+32.6%

Accounts Receivable

$141.07M

+12.6%

Inventory

$111.81M

-10.4%

Long Term Debt

$11.97M

-5.6%

Short Term Debt

$13.68M

-3.5%

Return on Assets

13.98%

N/A

Return on Invested Capital

20.54%

N/A

Free Cash Flow

$33.56M

+60.8%

Operating Cash Flow

$51.43M

+11.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CALZFPolyNovo Limited
$0.68-0.99%
BOIRFBoiron S.A.
$30.00+0.00%
JNDOFJINS HOLDINGS Inc.
$22.75+0.00%
BJTRFBeijing Tong Ren Tang Chinese Medicine Company Limited
$0.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
VRTVertiv
$255.88-0.05%

Questions About CLVSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.